Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results CC transcript Inv. presentation Acq. announced Appointed director
|
INSMED Inc (INSM)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/13/2023 |
4
| Smith Michael Alexander (General Counsel, Senior VP) has filed a Form 4 on INSMED Inc
Txns:
| Sold 740 shares
@ $20.18, valued at
$14.9k
|
|
05/17/2023 |
4
| Wise John Drayton (Chief Commercial Officer) has filed a Form 4 on INSMED Inc
Txns:
| Sold 593 shares
@ $19.29, valued at
$11.4k
Sold 381 shares
@ $18.44, valued at
$7k
Sold 1,913 shares
@ $18.17, valued at
$34.8k
|
|
05/17/2023 |
4
| Smith Michael Alexander (General Counsel, Senior VP) has filed a Form 4 on INSMED Inc
Txns:
| Sold 1,897 shares
@ $19.24, valued at
$36.5k
Sold 475 shares
@ $18.43, valued at
$8.8k
Sold 1,263 shares
@ $18.18, valued at
$23k
|
|
05/17/2023 |
4
| Schaeffer Orlov S Nicole (Chief People Strategy Officer) has filed a Form 4 on INSMED Inc
Txns:
| Sold 1,830 shares
@ $19.22, valued at
$35.2k
Sold 1,217 shares
@ $18.45, valued at
$22.5k
Sold 1,972 shares
@ $18.16, valued at
$35.8k
|
|
05/17/2023 |
4
| Lewis William (Chair and CEO) has filed a Form 4 on INSMED Inc
Txns:
| Sold 6,048 shares
@ $19.23, valued at
$116.3k
Sold 3,714 shares
@ $18.41, valued at
$68.4k
Sold 7,099 shares
@ $18.12, valued at
$128.6k
|
|
05/17/2023 |
4
| Flammer Martina M.D. (Chief Medical Officer) has filed a Form 4 on INSMED Inc
Txns:
| Sold 2,576 shares
@ $19.28, valued at
$49.7k
Sold 1,718 shares
@ $18.43, valued at
$31.7k
|
|
05/17/2023 |
4
| Bonstein Sara (CFO) has filed a Form 4 on INSMED Inc
Txns:
| Sold 2,210 shares
@ $19.3, valued at
$42.7k
Sold 1,610 shares
@ $18.47, valued at
$29.7k
|
|
03/17/2023 |
4
| SHAROKY MELVIN MD (Director) has filed a Form 4 on INSMED Inc
Txns:
| Gifted 3,798 shares
@ $0 |
|
01/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/02/2022 |
4
| SHAROKY MELVIN MD (Director) has filed a Form 4 on INSMED Inc
Txns:
| Bought 20,000 shares
@ $17.53, valued at
$350.6k
Bought 10,000 shares
@ $17.7, valued at
$177k
|
|
11/02/2022 |
4
| LEE LEO (Director) has filed a Form 4 on INSMED Inc
Txns:
| Bought 45,000 shares
@ $17.69, valued at
$796.1k
|
|
08/12/2022 |
4
| Wise John Drayton (Chief Commercial Officer) has filed a Form 4 on INSMED Inc
Txns:
| Sold 258 shares
@ $27.79, valued at
$7.2k
|
|
08/10/2022 |
4
| Lewis William (Chair and CEO) has filed a Form 4 on INSMED Inc
Txns:
| Sold 24,430 shares
@ $27.67, valued at
$676k
Sold 6,200 shares
@ $28.45, valued at
$176.4k
Sold 161,193 shares
@ $27.75, valued at
$4.5M
Sold 24,977 shares
@ $28.43, valued at
$710.1k
Exercised 30,630 options to buy
@ $3.4, valued at
$104.1k
Exercised 186,170 options to buy
@ $4.55, valued at
$847.1k
|
|
07/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/08/2022 |
4
| Lewis William (Chair and CEO) has filed a Form 4 on INSMED Inc
Txns:
| Sold 96,614 shares
@ $23, valued at
$2.2M
Exercised 96,614 options to buy
@ $16.16, valued at
$1.6M
|
|
05/25/2022 |
4
| Wise John Drayton (Chief Commercial Officer) has filed a Form 4 on INSMED Inc
Txns:
| Granted 26,236 shares
@ $0 Granted 164,580 options to buy
@ $20.01, valued at
$3.3M
|
|
05/18/2022 |
4
| Adsett Roger (COO) has filed a Form 4 on INSMED Inc
Txns:
| Sold 1,394 shares
@ $18.45, valued at
$25.7k
Sold 2,022 shares
@ $20.34, valued at
$41.1k
|
|
05/18/2022 |
4
| Bonstein Sara (CFO) has filed a Form 4 on INSMED Inc
Txns:
| Sold 1,433 shares
@ $18.51, valued at
$26.5k
|
|
05/18/2022 |
4
| Flammer Martina M.D. (Chief Medical Officer) has filed a Form 4 on INSMED Inc
Txns:
| Sold 1,574 shares
@ $18.51, valued at
$29.1k
|
|
|
|
|